8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0000950123-10-103946
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading y04177e8vk.htm…